ArticleJournal of diabetes science and technology2010
The food and drug administration is now preparing to establish tighter performance requirements for blood glucose monitors.
Article in Journal of diabetes science and technology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 37 citations in OpenAlex.
- A Milestone in Point of Care Capillary Blood Glucose Monitoring of Critically Ill Hospitalized Patients.Journal of diabetes science and technology · 2018Article
- Seven-Year Surveillance of the Clinical Performance of a Blood Glucose Test Strip Product.Journal of diabetes science and technology · 2017Article
- Performance of Cleared Blood Glucose Monitors.Journal of diabetes science and technology · 2015Review
- Why Have So Many Intravascular Glucose Monitoring Devices Failed?Journal of diabetes science and technology · 2015Review
- Challenges of inpatient blood glucose monitoring: standards, methods, and devices to measure blood glucose.Current diabetes reports · 2015Review
- The surveillance error grid.Journal of diabetes science and technology · 2014Article
- Analytical performance of glucose monitoring systems at different blood glucose ranges and analysis of outliers in a clinical setting.Journal of diabetes science and technology · 2014Article
- A new test strip technology platform for self-monitoring of blood glucose.Journal of diabetes science and technology · 2013Article
- Overview of fluorescence glucose sensing: a technology with a bright future.Journal of diabetes science and technology · 2012Review
- Effects of simulated altitude on blood glucose meter performance: implications for in-flight blood glucose monitoring.Journal of diabetes science and technology · 2012Article
- Intraoperative accuracy of a point-of-care glucose meter compared with simultaneous central laboratory measurements.Journal of diabetes science and technology · 2012Article
- Tighter accuracy standards within point-of-care blood glucose monitoring: how six commonly used systems compare.Journal of diabetes science and technology · 2012Article
- Accuracy in blood glucose measurement: what will a tightening of requirements yield?Journal of diabetes science and technology · 2012Article
- Blood glucose measurements in critically ill patients.Journal of diabetes science and technology · 2012Review
- The need for clinical accuracy guidelines for blood glucose monitors.Journal of diabetes science and technology · 2012Article
- Improving the safety of blood glucose monitoring.Journal of diabetes science and technology · 2011Article
- Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes.Journal of diabetes science and technology · 2011Article
- Performance evaluation and labeling comprehension of a new blood glucose monitoring system with integrated information management.Journal of diabetes science and technology · 2011Article
- Preanalytic and analytic accuracy: toward more realistic and meaningful self-monitoring of blood glucose submissions for regulatory approval.Journal of diabetes science and technology · 2011Article
- Accuracy of the CONTOUR® blood glucose monitoring system.Journal of diabetes science and technology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
On March 16 and 17, 2010, the Food and Drug Administration (FDA) presented a public meeting about blood glucose monitoring at the Gaithersberg Hilton Hotel. The meeting was intended to present expert opinions and solicit input from the public about whether to develop new regulatory policies for blood glucose monitors. The meeting was divided into three sections: (1) Clinical Accuracy Requirements for Blood Glucose Monitors, (2) Interferences and Limitations of Blood Glucose Monitors, and (3) Tight Glycemic Control. Many officials from the Center for Devices and Radiologic Health and the Office of In Vitro Diagnostic Devices, which are the parts of FDA that regulate approval of blood glucose monitors, either spoke on the agenda or attended in the audience. Approximately 300 people attended; they were mostly clinicians (such as adult endocrinologists, pediatric endocrinologists, internists, clinical chemists, intensivists, surgeons, nurses, and diabetes educators) or industry officials from companies involved in glucose monitoring, pharmaceutical products, data analysis, or regulatory consulting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.